JP2013018731A - Agent for improving brain function and food and drink for improving brain function - Google Patents

Agent for improving brain function and food and drink for improving brain function Download PDF

Info

Publication number
JP2013018731A
JP2013018731A JP2011152225A JP2011152225A JP2013018731A JP 2013018731 A JP2013018731 A JP 2013018731A JP 2011152225 A JP2011152225 A JP 2011152225A JP 2011152225 A JP2011152225 A JP 2011152225A JP 2013018731 A JP2013018731 A JP 2013018731A
Authority
JP
Japan
Prior art keywords
mass
rutin
hesperidin
brain function
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011152225A
Other languages
Japanese (ja)
Other versions
JP5779796B2 (en
Inventor
Masaaki Hayashibara
正明 林原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2011152225A priority Critical patent/JP5779796B2/en
Publication of JP2013018731A publication Critical patent/JP2013018731A/en
Application granted granted Critical
Publication of JP5779796B2 publication Critical patent/JP5779796B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a pharmaceutical product and/or food and drink for improving brain functions, each of which effectively improves memory and learning abilities that degrade with age, effectively improves cranial nerve disease such as dementia represented by Alzheimer disease, and can be safely and easily ingested by a human on a daily basis.SOLUTION: Each of the agent and/or food and drink for improving brain functions contains, as active ingredients, a water extract of Chinese parsley by 0.1 to 5 mass%, and includes transglycosylation rutin and/or transglycosylation hesperidin by 0.1 to 10 mass% in total.

Description

本発明は、ヒトが安全かつ日常的に手軽に摂取することのできる、脳機能改善用の医薬品又は飲食品に関するものである。   The present invention relates to a pharmaceutical or food / drink product for improving brain function that can be safely and routinely ingested by humans.

高齢化社会の到来にともない、心身ともに健康でありたいという願望は、以前にもましてより高まりつつある。ヒトは歳を重ねるにつれ、学習能力や記憶力が徐々に低下してゆく。この自然の摂理とは別に、アルツハイマー病やパーキンソン病などの痴呆症に罹患したときには、ヒトの尊厳までも脅かされる深刻な事態を招く場合があることから、痴呆症の予防と治療の研究が、近年、精力的に進められている。例えば、アルツハイマー病の治療剤として、ウシホスファチジルコリンやウシホスファチジルセリンを有効成分とする脳機能改善剤(特許文献1)、デフェロキサミンの塩を有効成分とする治療剤(特許文献2)、ドコサヘキサエン酸誘導体のエステル、アミド、トリグリセリド、リン脂質誘導体などを有効成分とする脳機能改善組成物(特許文献3)などを例示できる。   With the advent of an aging society, the desire to be healthy both physically and mentally is increasing. As humans grow older, their learning and memory skills gradually decline. Apart from this natural providence, dementia such as Alzheimer's disease and Parkinson's disease can lead to serious situations that threaten even the dignity of human beings. In recent years, it has been energetically advanced. For example, as a therapeutic agent for Alzheimer's disease, a brain function improving agent containing bovine phosphatidylcholine or bovine phosphatidylserine (Patent Literature 1), a therapeutic agent containing a salt of deferoxamine as an active ingredient (Patent Literature 2), a docosahexaenoic acid derivative Examples thereof include a brain function improving composition containing an ester, amide, triglyceride, phospholipid derivative or the like as an active ingredient (Patent Document 3).

しかしながら、上記薬剤は、その効果は別にして、それら薬剤の有効成分は食品素材として一般に流通しているものではなく、また、食経験が豊富なものでもないことから、ヒトが日常的に(継続的に)手軽に摂取できるものとは言い難い。   However, apart from the effects of the above drugs, the active ingredients of these drugs are not generally distributed as food materials and are not rich in food experience. (Continuously) It is hard to say that it can be ingested easily.

斯かる状況下において、ヒトの脳機能を効果的に改善する作用を有し、かつ、ヒトが安全かつ日常的に手軽に摂取することのできる脳機能改善用の医薬品や飲食品が当業界において強く求められていた。   Under such circumstances, pharmaceuticals and foods and drinks for improving brain function that have the action of effectively improving human brain function and that can be safely and daily consumed by humans are available in the industry. There was a strong demand.

一方、ルチン及びヘスペリジンは植物由来のフラボノイドであり、その生理機能もいくつか明らかにされている。そして、その水溶性を高めた糖転移ルチン及び/又は糖転移ヘスペリジンも開示されているが、これらの投与による作用として、学習能力や記憶力、あるいは、アルツハイマー病やパーキンソン病などの痴呆症との関連性について開示するものは見当たらない。   On the other hand, rutin and hesperidin are plant-derived flavonoids and their physiological functions have been clarified. Furthermore, glycosylated rutin and / or glycosylated hesperidin with increased water solubility are also disclosed, but as an effect of these administration, learning ability and memory ability, or relation to dementia such as Alzheimer's disease and Parkinson's disease There is no disclosure of sex.

特開平07−017855号公報Japanese Patent Laid-Open No. 07-017855 特開昭58−012123号公報JP 58-012123 A 特開平02−049723号公報Japanese Patent Laid-Open No. 02-049723

本発明は、加齢に伴う記憶・学習能力を効果的に改善するとともに、アルツハイマー病に代表される認知症などの脳神経疾患を効果的に改善する、ヒトが安全かつ日常的に手軽に摂取することのできる脳機能改善用の医薬品及び飲食品を提供することを目的とする。   The present invention effectively improves memory / learning ability associated with aging and effectively improves cranial nerve diseases such as dementia typified by Alzheimer's disease. It aims at providing the pharmaceutical and food-drinks for brain function improvement which can be performed.

上記目的を達成するため、本発明者らは、身近な食品素材の中から加齢に伴って生ずる記憶・学習能力を効果的に改善することのできる成分について鋭意研究の結果、有効成分として、中国パセリ水抽出物と、糖転移ルチン及び/又は糖転移ヘスペリジンとを所定の割合で含んでなる脳機能改善剤又は脳機能改善用飲食品が上記課題を解決することを見出し、本発明を完成するに至った。   In order to achieve the above-mentioned object, the present inventors, as an active ingredient, as a result of earnest research on ingredients that can effectively improve memory and learning ability that occurs with aging from familiar food materials, Discovered that a brain function improving agent or food / beverage product for improving brain function comprising a Chinese parsley water extract and sugar-transferred rutin and / or sugar-transferred hesperidin at a predetermined ratio solves the above-mentioned problems and completed the present invention. It came to do.

すなわち、本発明の実施形態は次のとおりである。
(1)有効成分として、中国パセリ水抽出物を0.1乃至5質量%含有し、糖転移ルチン及び/又は糖転移ヘスペリジンを合計で0.1乃至10質量%含んでなる、液状医薬品である脳機能改善剤。
(2)有効成分として、中国パセリ水抽出物を0.1乃至5質量%含有し、糖転移ルチン及び/又は糖転移ヘスペリジンを合計で0.1乃至10質量%含んでなり、かつ、pHが3乃至5である脳機能改善剤(例えば液状の医薬品)。
(3)少なくとも0.01質量%以上(好ましくは0.01乃至1質量%)のコーヒー抽出物をさらに含むことを特徴とする、(1)又は(2)に記載の脳機能改善剤。
(4)有効成分として、中国パセリ水抽出物を0.1乃至5質量%含有し、糖転移ルチン及び/又は糖転移ヘスペリジンを合計で0.1乃至10質量%含んでなる脳機能改善用飲食品。
(5)有効成分として、中国パセリ水抽出物を0.1乃至5質量%含有し、糖転移ルチン及び/又は糖転移ヘスペリジンを合計で0.1乃至10質量%含んでなり、かつ、pHが3乃至5である脳機能改善用飲食品。
(6)少なくとも0.01質量%以上(好ましくは0.01乃至1質量%)のコーヒー抽出物をさらに含むことを特徴とする、(4)又は(5)に記載の脳機能改善用飲食品。
That is, the embodiment of the present invention is as follows.
(1) A liquid pharmaceutical comprising 0.1 to 5% by mass of Chinese parsley water extract as an active ingredient and 0.1 to 10% by mass in total of transglycosyl rutin and / or transglycosyl hesperidin Brain function improving agent.
(2) Contains 0.1 to 5% by mass of Chinese parsley water extract as an active ingredient, 0.1 to 10% by mass in total of transglycosyl rutin and / or transglycosyl hesperidin, and has a pH of 3 to 5 brain function improving agents (for example, liquid pharmaceuticals).
(3) The brain function improving agent according to (1) or (2), further comprising at least 0.01% by mass (preferably 0.01 to 1% by mass) of a coffee extract.
(4) Brain function-improving food or drink containing 0.1 to 5% by mass of Chinese parsley water extract as an active ingredient and 0.1 to 10% by mass in total of transglycosyl rutin and / or transglycosyl hesperidin Goods.
(5) As an active ingredient, 0.1 to 5% by mass of a Chinese parsley water extract, 0.1 to 10% by mass in total of transglycosyl rutin and / or transglycosyl hesperidin, and having a pH of Food or drink for improving brain function, which is 3 to 5.
(6) The food or drink for improving brain function according to (4) or (5), further comprising at least 0.01% by mass (preferably 0.01 to 1% by mass) of coffee extract .

本発明によれば、本発明品をヒトが日常的に(継続的に)摂取することにより、高齢化に伴って生ずる、記憶・学習能力の低下を効果的に改善することができる。また、本発明品は、アルツハイマー病に代表される認知症などの脳神経疾患を効果的に改善することができる。本発明品の有効成分である、糖転移ルチン及び/又は糖転移ヘスペリジン、或いは、中国パセリ水抽出物、コーヒー抽出物のいずれも、従来より食品素材として長く用いられている成分であることから、これら成分を有効成分とする本発明品は、ヒトが日常的に安全かつ手軽に摂取できる利点を有する。   ADVANTAGE OF THE INVENTION According to this invention, when the human body takes this invention goods on a daily basis (continuous), the fall of memory and learning ability which arises with an aging can be improved effectively. The product of the present invention can effectively improve cranial nerve diseases such as dementia typified by Alzheimer's disease. From the fact that both the sugar-transferred rutin and / or sugar-transferred hesperidin, or the Chinese parsley water extract and the coffee extract, which are the active ingredients of the product of the present invention, have been used as food ingredients for a long time. The product of the present invention containing these components as an active ingredient has an advantage that humans can safely and easily take it on a daily basis.

本発明において脳機能改善とは、高齢化に伴って生ずる記憶・学習能力の低下を改善するとともに、認知症の代表的疾患であるアルツハイマー病などの症状を改善することを意味する。   In the present invention, improvement of brain function means improvement of a decrease in memory / learning ability caused by aging, and improvement of symptoms such as Alzheimer's disease, which is a typical disease of dementia.

本発明品の有効成分である中国パセリ(英名:コリアンダー)は、コエンドロ属に属する植物で、欧州においては、その葉部はシラントロと呼称される場合がある。一方、中国パセリは、日本国においては葉部、乾燥子実など部位を問わずコエンドロと呼称される場合がある。本発明で用いる中国パセリ水抽出物は、中国パセリの全草より根を除去したものを水で抽出して得られたものを意味する。すなわち、本発明で用いる中国パセリ水抽出物とは、中国パセリに含まれる成分の内、実質的に水で抽出される成分からなるものを意味する。   Chinese parsley (English name: coriander), which is an active ingredient of the product of the present invention, is a plant belonging to the genus Ciendro, and in Europe, its leaf part is sometimes called Cilantro. On the other hand, Chinese parsley is sometimes called a cilantro in Japan, regardless of the part of the leaf or dried grain. The Chinese parsley water extract used in the present invention means a product obtained by extracting water from a whole plant of Chinese parsley. That is, the Chinese parsley water extract used in the present invention means a component that is substantially extracted with water among components contained in Chinese parsley.

具体的な抽出方法としては、例えば、中国パセリの全草より根を除去したものを水洗し、水切りした後、ブレンダーを用いて細断(ミンチ)し、これを遠心分離器を用いてフィルターを通して濾過する。得られた濾液を121℃で10分間加熱処理し、室温まで放冷し、本発明で用いる中国パセリ水抽出物を得ることができる。斯くして得られる中国パセリ水抽出物は、通常、ポリフェノールを500乃至20,000μg/ml程度含有している。なお、中国パセリ水抽出物の固形物濃度は、中国パセリを加熱するときの温度、時間により変動するものの、本発明品に含まれる中国パセリの量は、上記中国パセリ水抽出物中に含まれるポリフェノール含量を基準とする。すなわち、本発明品では多くの場合、ポリフェノールとともに中国パセリ水抽出物中に含まれるポリフェノール以外の他の成分を含むが、本発明品に含まれる中国パセリ水抽出物の量とは、上記中国パセリ水抽出物中に含まれるポリフェノール含量を意味する。   As a specific extraction method, for example, after removing roots from whole grass of Chinese parsley, draining, and then mincing with a blender, and passing this through a filter using a centrifuge Filter. The obtained filtrate is heat-treated at 121 ° C. for 10 minutes and allowed to cool to room temperature to obtain a Chinese parsley water extract used in the present invention. The Chinese parsley water extract thus obtained usually contains about 500 to 20,000 μg / ml of polyphenol. Although the solids concentration of the Chinese parsley water extract varies depending on the temperature and time when the Chinese parsley is heated, the amount of Chinese parsley contained in the product of the present invention is included in the above Chinese parsley water extract. Based on polyphenol content. That is, in many cases, the product of the present invention contains other components other than polyphenol contained in the Chinese parsley water extract together with polyphenol. The amount of the Chinese parsley water extract contained in the product of the present invention It means the polyphenol content contained in the water extract.

本発明品における中国パセリ水抽出物の好適な含量は、0.1乃至10質量%、好適には、0.1乃至5質量%、より好適には、0.5乃至3質量%である。中国パセリ水抽出物を上記範囲で後述する糖転移ルチン及び/又は糖転移ヘスペリジンと併用したときには、本発明の所期の効果が効果的ないしは相乗的に高まる利点がある。一方、中国パセリ水抽出物の濃度が上記下限又は上限を外れる場合には、糖転移ルチン及び/又は糖転移ヘスペリジンと併用しても、それら併用による十分な効果は得られない。   The preferred content of the Chinese parsley water extract in the product of the present invention is 0.1 to 10% by mass, preferably 0.1 to 5% by mass, and more preferably 0.5 to 3% by mass. When a Chinese parsley water extract is used in combination with sugar-transferred rutin and / or sugar-transferred hesperidin, which will be described later in the above range, the desired effect of the present invention is effectively or synergistically increased. On the other hand, when the concentration of the Chinese parsley water extract is out of the above lower limit or upper limit, even if it is used in combination with glycosylated rutin and / or glycosylated hesperidin, sufficient effects due to the combined use cannot be obtained.

本発明品の有効成分である糖転移ルチンとは、ルチンにおけるD−グルコースの4位の位置にD−グルコース分子がα−1,4結合で等モル以上(通常、1乃至20個)結合したα−グリコシル ルチン、又はD−グルコースの分子数が異なる各種α−グリコシル ルチンの混合物を意味する。糖転移ルチンは、従来より、食品、化粧品、医薬品等の分野で用いられている安全性の高い物質であり、生体内の酵素の作用を受けて、最終的にルチンとD−グルコースとに加水分解され、ルチン本来の生理学的作用を発揮する。なお、ルチンの生理学的作用としては、毛細血管強化作用、出血予防作用、血圧調節作用等を挙げることができる。   The transglycosyl rutin, which is an active ingredient of the product of the present invention, is an equimolar or more (usually 1 to 20) D-glucose molecule bound by α-1,4 bond at the 4-position of D-glucose in rutin. It means α-glycosyl rutin or a mixture of various α-glycosyl rutins having different molecular numbers of D-glucose. Glucose transfer rutin is a highly safe substance that has been used in the fields of food, cosmetics, pharmaceuticals, etc., and is finally hydrolyzed into rutin and D-glucose by the action of enzymes in the body. It is degraded and exerts its original physiological effects. Examples of the physiological action of rutin include capillary strengthening action, bleeding prevention action, blood pressure regulation action and the like.

本発明品の有効成分である糖転移ヘスペリジンとは、ヘスペリジンにおけるD−グルコースの4位の位置にD−グルコース分子がα−1,4結合で等モル以上(通常、1乃至20個)結合したα−グリコシル ヘスペリジン、又はD−グルコースの分子数が異なる各種α−グリコシル ヘスペリジンの混合物を意味する。糖転移ヘスペリジンは、従来より、食品、化粧品、医薬品等の分野で用いられている安全性の高い物質であり、生体内の酵素の作用を受けて、最終的にヘスペリジンとD−グルコースとに加水分解され、ヘスペリジン本来の生理学的作用を発揮する。ヘスペリジンの生理学的作用としては、毛細血管強化作用、出血予防作用、血圧調節作用等を挙げることができる。   The transglycosylated hesperidin, which is an active ingredient of the product of the present invention, is an equimolar or more (usually 1 to 20) D-glucose molecule bonded with α-1,4 bond at the 4-position of D-glucose in hesperidin. It means α-glycosyl hesperidin or a mixture of various α-glycosyl hesperidins having different numbers of D-glucose molecules. Glycosylated hesperidin is a highly safe substance conventionally used in the fields of foods, cosmetics, pharmaceuticals, etc., and is finally hydrolyzed into hesperidin and D-glucose under the action of enzymes in the body. It is degraded and exerts the original physiological effects of hesperidin. Examples of the physiological action of hesperidin include capillary strengthening action, bleeding prevention action, blood pressure regulation action and the like.

上記糖転移ルチン及び糖転移ヘスペリジンは、種々の方法で調製することができるが、経済性の観点からは、糖転移酵素を用いる生化学的方法が有利である。当該方法としては、例えば、澱粉部分加水分解物やマルトオリゴ糖などのα−グルコシル糖化合物の存在下で、ルチン又はヘスペリジンに、α−グルコシダーゼ、シクロマルトデキストリン・グルカノトランスフェラーゼ、及びα−アミラーゼを始めとする複数種類の酵素を作用させることにより高収量で得ることができる。斯かる酵素反応については、特開平3−7593号公報、特開平3−27293号公報、特開平3−58790号公報、及び特開平3−115292号公報、特開平10−70994号公報、特願平9−69588号公報などに記載された方法を例示することができる。斯かる方法により調製された市販品としては、糖転移ルチン粉末(商品名『αGルチンP』(固形分重量当りの全ルチン含量40乃至44%)、あるいは、商品名『αGルチンPS』(固形分重量当りの全ルチン含量80乃至84%)、いずれも東洋精糖株式会社)及び糖転移ヘスペリジン粉末(商品名『林原ヘスペリジンS』(固形分重量当りの全ヘスペリジン含量70%以上)、株式会社林原商事)がある。なお、使用方法にもよるが、本発明においては、糖転移ルチン及び糖転移ヘスペリジンは必ずしも、最高純度にまで精製されていなくてもよく、所期の目的を著しく妨げない限り、それらの調製方法に由来する夾雑物を含む形態のものであってもよい。   The above-mentioned glycosyl rutin and glycosyl hesperidin can be prepared by various methods, but from the viewpoint of economy, a biochemical method using a glycosyltransferase is advantageous. Examples of the method include rutin or hesperidin, α-glucosidase, cyclomaltodextrin / glucanotransferase, and α-amylase in the presence of an α-glucosyl sugar compound such as a partially hydrolyzed starch or maltooligosaccharide. Can be obtained in a high yield by allowing a plurality of types of enzymes to act. Regarding such enzyme reaction, JP-A-3-7593, JP-A-3-27293, JP-A-3-58790, JP-A-3-115292, JP-A-10-70994, Japanese Patent Application No. A method described in Japanese Patent Laid-Open No. 9-69588 can be exemplified. Commercially-available products prepared by such a method include sugar-transferred rutin powder (trade name “αG rutin P” (total rutin content 40 to 44% per solid weight) or trade name “αG rutin PS” (solid (All rutin content per minute weight 80 to 84%), all Toyo Seika Co., Ltd.) and sugar-transferred hesperidin powder (trade name “Hayashibara Hesperidin S” (total hesperidin content 70% or more per solid weight), Hayashibara Co., Ltd. Trading). Although depending on the method of use, in the present invention, the sugar-transferred rutin and the sugar-transferred hesperidin do not necessarily have to be purified to the highest purity, and their preparation methods are not required unless they significantly disturb the intended purpose. The thing of the form containing the contaminant originating in may be sufficient.

本発明品に含まれる糖転移ルチン及び/又は糖転移ヘスペリジンの好適な含量は、それらの合計で、0.1乃至10質量%、より好適には、0.5乃至5質量%、更に好適には、0.8乃至5質量%である。また、糖転移ルチン及び/又は糖転移ヘスペリジンの合計量が、上記下限及び/又は上限を逸脱する場合には、本発明が奏する作用効果が著しく低下するか発揮されなくなることから好ましくない。なお、本発明品に含まれる糖転移ルチン及び/又は糖転移ヘスペリジンの量とは、試料中に含まれる全ルチン量及び/又は全ヘスペリジン量を意味する。   The preferred content of transglycosyl rutin and / or transglycosyl hesperidin contained in the product of the present invention is 0.1 to 10% by mass in total, more preferably 0.5 to 5% by mass, and still more preferably. Is 0.8 to 5% by mass. Moreover, when the total amount of glycosylated rutin and / or glycosylated hesperidin deviates from the above lower limit and / or upper limit, it is not preferable because the effects achieved by the present invention are significantly reduced or not exhibited. The amount of transglycosyl rutin and / or transglycosyl hesperidin contained in the product of the present invention means the total rutin and / or total hesperidin contained in the sample.

本発明品は、有効成分として、中国パセリ水抽出物、糖転移ルチン及び/又は糖転移ヘスペリジンを上記範囲で含むものである限り、その製造方法は限定されない。例示すれば、所定量の水と、有効成分としての中国パセリ水抽出物、糖転移ルチン及び/又は糖転移ヘスペリジンとを均一に混合して、有効成分が上記所定の範囲で含まれるよう調製し、これを公知の精密濾過法、紫外線滅菌法、加熱滅菌法、放射線滅菌法、加圧滅菌法、及び加圧蒸気滅菌法から選ばれる1種又は2種以上の滅菌方法により滅菌した後、適宜の材質、形状、容量の容器に無菌的に充填するか、滅菌前の液体を適宜の容器に充填した後、上記1種又は2種以上の滅菌方法を適宜適用し、滅菌することも随意である。上記容器としては、保存期間中に品質を実質的に変化させることのない、透明ないしは遮光性のガラス製容器、金属製容器、紙製容器、更には、ポリエチレン製容器、ポリエチレンテレフタレート製容器、及びポリプロピレン製容器などのプラスチック容器及びパウチ容器などを例示できる。これら容器の容量に制限はないが、例えば、1ml以上、50ml以上、0.1乃至2L、5乃至25L、或いは100乃至2,000Lなどの容器を適宜選択して用いることができる。更に、本発明品を大量に輸送する場合には、適宜容積のコンテナ、タンクローリー、タンカーなどに充填して輸送することも随意である。   The production method of the product of the present invention is not limited as long as it contains Chinese parsley water extract, sugar-transferred rutin and / or sugar-transferred hesperidin in the above range as active ingredients. For example, a predetermined amount of water and a Chinese parsley water extract as an active ingredient, sugar-transferred rutin and / or sugar-transferred hesperidin are uniformly mixed, and the active ingredient is prepared so as to be included in the predetermined range. After sterilizing this by one or more sterilization methods selected from known microfiltration, ultraviolet sterilization, heat sterilization, radiation sterilization, autoclave, and autoclave sterilization, After aseptically filling a container of the material, shape and capacity of the above, or filling an appropriate container with a liquid before sterilization, one or more of the above sterilization methods may be appropriately applied and sterilized. is there. As the container, a transparent or light-shielding glass container, a metal container, a paper container, or a polyethylene container, a polyethylene terephthalate container, and the like, which do not substantially change the quality during the storage period, and Examples thereof include plastic containers such as polypropylene containers and pouch containers. Although there is no restriction | limiting in the capacity | capacitance of these containers, For example, containers, such as 1 ml or more, 50 ml or more, 0.1 to 2L, 5 to 25L, or 100 to 2,000L, can be selected suitably and can be used. Furthermore, when a large amount of the product of the present invention is transported, it is optional to fill and transport the container, tank lorry, tanker, etc. of an appropriate volume.

本発明品の形態は、上記のような液状のみならず、ゲル状、ペースト状などのヒトが経口的に摂取可能な形態の医薬品、医薬部外品、飲食品(飲料を含む)全般を意味する。本発明品は、特に液状の場合、酸性側のpH、好適には、pH3乃至5、より好適には、pH3〜4.5、更に好適には、pH3.5〜4の範囲に調整されていることが望ましい。本発明品のpHは、適宜のpH調製剤を用いて、前記範囲となるように調整する。pH調製剤としては、食品添加物として認められているものであればいずれも用いることができる。しかしながら、本発明においては、酢酸、クエン酸などの有機酸、及びそれらの塩類をpH調製剤として用いるときには、本発明の所期の作用効果がより顕著に発揮される利点がある。なお、pHが上記範囲の下限を下回るか、上限を上回る場合には、本発明の所期の作用効果が著しく低減するか、発揮されなくなるとともに、有効成分の保存安定性が低下したり、呈味が著しく低下することから好ましくない。   The form of the product of the present invention means not only liquids as described above, but also general drugs, quasi-drugs, foods and drinks (including beverages) that can be taken orally by humans, such as gels and pastes. To do. The product of the present invention is adjusted to an acidic pH, preferably pH 3 to 5, more preferably pH 3 to 4.5, and still more preferably pH 3.5 to 4, particularly in a liquid state. It is desirable that The pH of the product of the present invention is adjusted to fall within the above range using an appropriate pH adjuster. Any pH adjusting agent can be used as long as it is recognized as a food additive. However, in the present invention, when organic acids such as acetic acid and citric acid and salts thereof are used as a pH adjuster, there is an advantage that the intended effects of the present invention are more remarkably exhibited. When the pH is lower than the lower limit of the above range or higher than the upper limit, the intended effect of the present invention is remarkably reduced or not exhibited, and the storage stability of the active ingredient is reduced or exhibited. This is not preferable because the taste is significantly reduced.

本発明品の有効成分はいずれも、ヒトが安心して摂取することのできる安全性の高いものであること、また、上記成分のいずれも、工業的に安定して安価に供給されるものであることから、本発明品は、工業的に安価かつ安定して提供される利点を有している。   All of the active ingredients of the product of the present invention are highly safe and can be safely ingested by humans, and all of the above ingredients are industrially stable and inexpensively supplied. Therefore, the product of the present invention has an advantage that it is industrially inexpensive and stably provided.

そして、本発明品に対し、その所期の効果を妨げない範囲で、アルコール、澱粉質、蛋白質、アミノ酸、繊維質、糖質(グルコース、マルトース、トレハロースなど)、糖アルコール(ソルビトール、マルチトールなど)、脂質、必須脂肪酸等をはじめとする脂肪酸、ビタミン類(L−アスコルビン酸、2−O−α−D−グルコシル−L−アスコルビン酸など)、ミネラル類(マグネシウム、カルシウム、亜鉛、カリウム、鉄、ナトリウム及びそれらの塩など)、漢方薬、着香料、着色料、甘味料、調味料(スクラロース、サッカリン、ステビア、アスパルテームなどの高甘味度甘味料を含む)、安定剤、防腐剤などの食品等に通常用いられる原料及び/又は素材の1種又は2種以上を配合することができる。また、添加剤、安定化剤、界面活性剤、防腐剤(抗菌剤)、増粘剤、抗酸化剤、キレート剤、水性媒体、水溶性高分子、pH調整剤、発泡剤などの医薬品・医薬部外品製剤製造における製剤学的に許容される成分の1種又は2種以上を適宜組み合わせて配合した医薬製剤とすることもできる。そして、対象とする食品組成物や製剤の組成やその使用目的を勘案し、原料の段階から製品が完成するまでの工程で有効成分を配合すればよい。   And to the product of the present invention, alcohol, starch, protein, amino acid, fiber, sugar (glucose, maltose, trehalose, etc.), sugar alcohol (sorbitol, maltitol, etc.) as long as the desired effect is not hindered. ), Fatty acids including lipids, essential fatty acids, vitamins (L-ascorbic acid, 2-O-α-D-glucosyl-L-ascorbic acid, etc.), minerals (magnesium, calcium, zinc, potassium, iron) , Sodium and their salts, etc.), herbal medicine, flavoring, coloring, sweetener, seasoning (including high-intensity sweeteners such as sucralose, saccharin, stevia, aspartame), stabilizers, preservatives, etc. 1 type, or 2 or more types of the raw material and / or raw material which are normally used can be mix | blended. In addition, pharmaceuticals and pharmaceuticals such as additives, stabilizers, surfactants, preservatives (antibacterial agents), thickeners, antioxidants, chelating agents, aqueous media, water-soluble polymers, pH adjusters, foaming agents, etc. It can also be set as the pharmaceutical formulation which mix | blended combining suitably 1 type, or 2 or more types of the pharmacologically acceptable component in quasi-drug preparation manufacture. Then, in consideration of the composition of the target food composition or preparation and the purpose of use, the active ingredient may be blended in the process from the raw material stage to the completion of the product.

本発明品は、ヒトが日常的に経口摂取することにより、加齢に伴う記憶・学習能力を効果的に改善することができるが、その用量は、通常、成人当たり、5乃至1,000mL/日、望ましくは、25乃至500mL/日、より望ましくは、50乃至500mL/日の量を、1乃至10回/日、望ましくは、3乃至6回/日の頻度で毎日、又は数日間の間隔をおいて1週間以上、好適には、1カ月以上、より好適には、6カ月以上に亘って摂取する。   The product of the present invention can effectively improve the memory / learning ability associated with aging by daily oral intake by humans. The dose is usually 5 to 1,000 mL / adult per adult. Daily, preferably 25 to 500 mL / day, more preferably 50 to 500 mL / day in an amount of 1 to 10 times / day, preferably 3 to 6 times / day at intervals of every day or several days Ingestion for 1 week or longer, preferably 1 month or longer, more preferably 6 months or longer.

本発明品の適用対象としては、加齢に伴う記憶・学習能力の低下を抑制ないしは改善したいヒト、又はアルツハイマーが発症ないしはその発症が危惧されるヒトを例示できる。また、本発明の脳機能改善用飲料は、加齢に伴う記憶・学習能力の低下を抑制ないしは改善できるだけでなく、健康の維持・増進にも優れた効果を発揮する。   Examples of the application target of the present invention include humans who want to suppress or improve the decrease in memory / learning ability associated with aging, or humans who develop or are at risk of developing Alzheimer's. In addition, the beverage for improving brain function of the present invention can not only suppress or improve a decrease in memory / learning ability associated with aging, but also exhibits an excellent effect for maintaining and promoting health.

以下、本発明の実施例について述べるが、本発明はこれらの実施例のみに限定されるものではなく、本発明の技術的思想内においてこれらの様々な変形が可能である。   Examples of the present invention will be described below, but the present invention is not limited to these examples, and various modifications can be made within the technical idea of the present invention.

(脳機能改善用飲料剤等の製造)
本発明品及び比較対照品等を、以下のとおり製造した。
(Manufacture of beverages for improving brain function)
The product of the present invention and comparative products were produced as follows.

糖転移ヘスペリジン粉末(商品名『林原ヘスペリジンS』(固形分重量当りの全ヘスペリジン含量70%以上)、株式会社林原商事)2質量部と精製水10質量部とを均一に攪拌混合し、酢酸ナトリウムでpH3.8に調整し、精密濾過して飲料剤を得た(参考例1)。   2 parts by mass of sugar-transferred hesperidin powder (trade name “Hayashibara Hesperidin S” (total hesperidin content of 70% or more by weight of solid content), Hayashibara Corporation) and 10 parts by mass of purified water are stirred and mixed uniformly. Was adjusted to pH 3.8 and finely filtered to obtain a beverage (Reference Example 1).

糖転移ルチン粉末(商品名『αGルチンPS』(固形分重量当りの全ルチン含量80乃至84%)、東洋精糖株式会社)0.8質量部と精製水10質量部とを均一に攪拌混合し、酢酸ナトリウムでpH3.8に調整し、精密濾過して飲料剤を得た(参考例2)。   Glucose transfer rutin powder (trade name “αG rutin PS” (total rutin content per solid content weight 80 to 84%), Toyo Seika Co., Ltd.) 0.8 parts by mass and 10 parts by mass of purified water are stirred and mixed uniformly. Then, the pH was adjusted to 3.8 with sodium acetate, followed by microfiltration to obtain a beverage (Reference Example 2).

収穫した中国パセリの全草より根を除去し、これを水洗し、水切りした後、ブレンダーを用いて細断(ミンチ)した。細断した中国パセリを遠心濾過分離器(回転数3,000rpm)を用いて150メッシュ・フィルターを用いて濾過した。濾液を回収し、121℃で10分間処理し、25℃まで放冷して、中国パセリ水抽出物を得た(参考例3)。当該抽出物中のポリフェノール含量は約1,000μg/mlであった。   Roots were removed from the whole harvested Chinese parsley, washed with water, drained, and then minced with a blender. The shredded Chinese parsley was filtered using a 150 mesh filter using a centrifugal filter separator (number of revolutions 3,000 rpm). The filtrate was collected, treated at 121 ° C. for 10 minutes, and allowed to cool to 25 ° C. to obtain a Chinese parsley water extract (Reference Example 3). The polyphenol content in the extract was about 1,000 μg / ml.

参考例3で得た中国パセリ水抽出物0.3質量部、糖転移ルチン粉末(商品名『αGルチンPS』(固形分重量当りの全ルチン含量80乃至84%)、東洋精糖株式会社)1質量部、及び精製水10質量部を均一に攪拌混合し、酢酸ナトリウムでpH3.8に調整し、精密濾過して、本発明品である飲料剤を得た(試験例1)。   0.3 parts by mass of Chinese parsley water extract obtained in Reference Example 3, sugar-transferred rutin powder (trade name “αG rutin PS” (total rutin content 80 to 84% per solid weight), Toyo Seika Co., Ltd.) 1 Part by mass and 10 parts by mass of purified water were uniformly stirred and mixed, adjusted to pH 3.8 with sodium acetate, and subjected to microfiltration to obtain a beverage preparation according to the present invention (Test Example 1).

参考例3で得た中国パセリ水抽出物0.3質量部、糖転移ヘスペリジン粉末(商品名『林原ヘスペリジンS』(固形分重量当りの全ヘスペリジン含量70%以上)、株式会社林原商事)1.2質量部、及び精製水10質量部を均一に攪拌混合し、酢酸ナトリウムでpH3.8に調整し、精密濾過して、本発明品である飲料剤を得た(試験例2)。   0.3 parts by mass of Chinese parsley water extract obtained in Reference Example 3, sugar-transferred hesperidin powder (trade name “Hayashibara Hesperidin S” (total hesperidin content of 70% or more per solid weight), Hayashibara Corporation) 2 parts by mass and 10 parts by mass of purified water were stirred and mixed uniformly, adjusted to pH 3.8 with sodium acetate, and subjected to microfiltration to obtain a beverage preparation according to the present invention (Test Example 2).

参考例3で得た中国パセリ水抽出物2質量部、糖転移ルチン粉末(商品名『αGルチンPS』(固形分重量当りの全ルチン含量80乃至84%)、東洋精糖株式会社)2質量部、糖転移ビタミンC粉末(商品名『アスコフレッシュ』、株式会社林原商事)0.2質量部、酢酸ナトリウム0.05質量部、クエン酸2質量部、コーヒー抽出物0.01質量部、及び精製水75質量部を均一に攪拌混合し、酢酸でpH3.7に調整し、精密濾過して、本発明品である飲料剤を得た(試験例3)。   2 parts by weight of Chinese parsley water extract obtained in Reference Example 3, sugar-transferred rutin powder (trade name “αG rutin PS” (total rutin content 80 to 84% per solid weight), 2 parts by weight of Toyo Seika Co., Ltd.) , Sugar transfer vitamin C powder (trade name “Asco Fresh”, Hayashibara Shoji Co., Ltd.) 0.2 parts by weight, sodium acetate 0.05 parts by weight, citric acid 2 parts by weight, coffee extract 0.01 parts by weight, and purification 75 parts by mass of water was uniformly stirred and mixed, adjusted to pH 3.7 with acetic acid, and subjected to microfiltration to obtain a beverage that is the product of the present invention (Test Example 3).

参考例3で得た中国パセリ水抽出物0.5質量部、糖転移ヘスペリジン粉末(商品名『林原ヘスペリジンS』(固形分重量当りの全ヘスペリジン含量70%以上)、株式会社林原商事)1.5質量部、糖転移ビタミンC粉末(商品名『アスコフレッシュ』、株式会社林原商事)0.1質量部、酢酸ナトリウム0.05質量部、クエン酸2質量部、コーヒー抽出物0.01質量部、及び精製水75質量部とを均一に攪拌混合し、酢酸ナトリウムでpH3.5に調整し、精密濾過して、本発明品である飲料剤を得た(試験例4)。   1. 0.5 parts by mass of Chinese parsley water extract obtained in Reference Example 3, sugar-transferred hesperidin powder (trade name “Hayashibara Hesperidin S” (total hesperidin content of 70% or more per solid weight), Hayashibara Corporation) 5 parts by mass, sugar-transferred vitamin C powder (trade name “Asco Fresh”, Hayashibara Shoji Co., Ltd.) 0.1 part by mass, sodium acetate 0.05 part by mass, citric acid 2 parts by mass, coffee extract 0.01 part by mass And 75 parts by mass of purified water were stirred and mixed uniformly, adjusted to pH 3.5 with sodium acetate, and subjected to microfiltration to obtain a beverage preparation according to the present invention (Test Example 4).

参考例3で得た中国パセリ水抽出物0.3質量部、糖転移ルチン粉末(商品名『αGルチンPS』(固形分重量当りの全ルチン含量80乃至84%)、東洋精糖株式会社)1質量部、糖転移ヘスペリジン粉末(商品名『林原ヘスペリジンS』(固形分重量当りの全ヘスペリジン含量70%以上、株式会社林原商事)1質量部、及び精製水10質量部を均一に攪拌混合し、酢酸ナトリウムでpH3.8に調整し、精密濾過して、本発明品である飲料剤を得た(試験例5)。   0.3 parts by mass of Chinese parsley water extract obtained in Reference Example 3, sugar-transferred rutin powder (trade name “αG rutin PS” (total rutin content 80 to 84% per solid weight), Toyo Seika Co., Ltd.) 1 1 part by mass, sugar-transferred hesperidin powder (trade name “Hayashibara Hesperidin S” (total hesperidin content of 70% or more by weight of solid content, Hayashibara Corporation) and 10 parts by mass of purified water are stirred and mixed uniformly. The pH was adjusted to 3.8 with sodium acetate, and the solution was microfiltered to obtain a beverage that is the product of the present invention (Test Example 5).

試験例1〜5に示した本発明品は、これをヒトが日常的に(継続的に)摂取することにより、高齢化に伴って生ずる、記憶・学習能力の低下を効果的に改善することができる。また、これらの飲料剤は、アルツハイマー病に代表される痴呆症などの脳神経疾患を効果的に改善することができる。   The products of the present invention shown in Test Examples 1 to 5 effectively improve the decline in memory / learning ability that occurs with aging by daily (continuous) ingestion by humans. Can do. In addition, these beverages can effectively improve cranial nerve diseases such as dementia typified by Alzheimer's disease.

(脳機能改善用飲料剤等の効果確認試験I)
実施例1で得られた飲料剤等について、その脳機能改善効果をラットで比較確認するため以下の試験を実施した。
(Effectiveness confirmation test I for beverages for improving brain function I)
The following tests were conducted on the beverages obtained in Example 1 in order to compare and confirm the brain function improvement effect in rats.

老齢ラットとしてウィスター系雄ラット(80週齢)20匹を無作為に5匹ずつA乃至D群の4群に分け、これら4群のラットを標準飼料と下記表1に示す飲用水を用いて、同一環境下で飼育した。   As old rats, 20 Wistar male rats (80-week-old) were randomly divided into 4 groups of groups A to D, each of which was divided into 5 groups using the standard feed and drinking water shown in Table 1 below. Bred in the same environment.

Figure 2013018731
Figure 2013018731

A乃至D群のラットを10週間飼育した後、モーリス水迷路(J.Neurosci.Meth.,第11巻、47乃至60頁、1984年)を用いた学習・記憶能力に関する水迷路試験を行った。すなわち、円形のプール(直径180cm、深さ70cm)に、円形プラットホーム(直径20cm、高さ30cm)を置き、プラットホームの面が隠れるようにプラットホームの上2cmまで水を入れた。各ラットを毎回違うスタート位置から遊泳させ、プラットホーム上でラットが5秒間以上、止まるまでの時間(Escape Latency:EL)を測定した。EL測定時間は、動物愛護の観点から最大80秒とした。本試験を3日毎に1日1回、3週間に亘って計7回行った。試験結果として、60秒以内にプラットホームに上がったラットの比率(%)を下記表2に、プラットホーム上でラットが5秒間以上、止まる迄の時間を下記表3に示す。   After rats A to D were bred for 10 weeks, a water maze test for learning and memory ability was performed using the Morris water maze (J. Neurosci. Meth., 11, 47-60, 1984). . That is, a circular platform (diameter 20 cm, height 30 cm) was placed in a circular pool (diameter 180 cm, depth 70 cm), and water was poured up to 2 cm above the platform so that the surface of the platform was hidden. Each rat was allowed to swim from a different start position each time, and the time until the rat stopped on the platform for at least 5 seconds (Escape Latency: EL) was measured. The EL measurement time was set to a maximum of 80 seconds from the viewpoint of animal welfare. This test was conducted once every three days once a day for a total of seven times over a three week period. As a test result, the ratio (%) of the rats that have risen to the platform within 60 seconds is shown in Table 2 below, and the time until the rat stops on the platform for 5 seconds or more is shown in Table 3 below.

Figure 2013018731
Figure 2013018731

Figure 2013018731
Figure 2013018731

上記水迷路試験において、各群のラットいずれもが60秒以内にプラットホームに達する割合は、試験を重ねるにつれ上昇した。しかも、ラットがプラットホーム上に5秒間以上、止まる時間は、試験を重ねるにつれ短縮していることから、各試験群のラットのいずれも、プラットホームに上がることにより水から待避できることを学習・記憶したと判断される。60秒以内にプラットホームに達するラットの比率は、A乃至D群のラットの内、D群のラットが最も高く、逆にA群のラットは最も低かった。B群、C群のラットは同等であった。一方、プラットホームにラットが5秒間以上、止まるまでの時間は、A乃至D群のラットの内、D群のラットが最も短かく、逆にA群のラットは最も長かった。B群、C群のマウスは同等であった。   In the water maze test, the rate at which all rats in each group reached the platform within 60 seconds increased as the test was repeated. Moreover, since the time for which the rat stays on the platform for 5 seconds or longer has been shortened as the test is repeated, it has been learned and memorized that each rat in each test group can escape from the water by going up to the platform. To be judged. The proportion of rats that reached the platform within 60 seconds was the highest in the D group rats among the A to D group rats, and conversely the lowest in the A group rats. The rats in Group B and Group C were equivalent. On the other hand, the time until the rats stopped on the platform for 5 seconds or longer was the shortest among the rats in the groups A to D, and the longest the rats in the group A. The mice in Group B and Group C were equivalent.

本試験結果から、脳機能改善用飲料剤(D群)は、学習・記憶能力を効果的に改善する作用を有していることが判明した。   From this test result, it was found that the brain function improving beverage (Group D) has an action of effectively improving learning / memory ability.

(脳機能改善用飲料剤等の効果確認試験II)
実施例1で得られた飲料剤等について、その脳機能改善効果をヒトで比較確認するため以下の試験を実施した。
(Effect confirmation test II for beverages for improving brain function, etc.)
The following tests were conducted on the beverages obtained in Example 1 in order to compare and confirm the brain function improvement effect in humans.

身体的に健康な60乃至70歳の老人35名(男性15名、女性20名)を被験者とし、試験例2に示す本発明品を毎日朝食後、50mL/日の割合で12週間に亘って飲用させ、飲用を開始してから6週間目と、12週間目の最終飲用後、1週間目にそれぞれ、各被験者の記憶力を評価した。評価方法は、ティー・クルーク(T.Crook)等が考案したMAC法(Neurology、第41巻、644乃至649頁、1991年)を用いた。MAC法は、人の顔と名前とを記憶すること、電話番号を記憶すること、買い物リストを記憶することなど、日常生活における記憶力を調べ、評価する方法である。MAC法を用いて被験者全員の記憶年齢を算出し、平均値を求めたところ、試験開始時は66.5歳であったものが、飲用を開始してから6週間目には、64.2歳となり、12週間目の最終飲用後、1週間目には62.8歳となった。   Thirty-five elderly persons (15 males and 20 females) who are physically healthy 60 to 70 years old were subjects, and after daily breakfast, the product of the present invention shown in Test Example 2 was served at a rate of 50 mL / day for 12 weeks. The subjects were allowed to drink, and the memory ability of each subject was evaluated at 6 weeks after the start of drinking and 1 week after the final drinking at 12 weeks, respectively. The evaluation method used was the MAC method (Neurology, Vol. 41, pages 644 to 649, 1991) devised by T. Crook and others. The MAC method is a method for examining and evaluating memory ability in daily life, such as storing a person's face and name, storing a telephone number, and storing a shopping list. The memory age of all the subjects was calculated using the MAC method, and the average value was obtained. The result was 66.5 years old at the start of the test, but 64.2 weeks after the start of drinking. He became 62.8 years old in the first week after the last drink in the 12th week.

また、本実験終了後、上記被験者全員につき、本発明の飲料剤を飲用させないで、1カ月間通常の生活を送らせた後、上記MAC法を用いて被験者全員の記憶年齢を算出し、平均値を求めたところ、65.5歳となった。   In addition, after the end of this experiment, for all the subjects, after having allowed them to live a normal life for one month without drinking the beverage of the present invention, the memory age of all the subjects was calculated using the MAC method, and the average When the value was calculated, it became 65.5 years old.

これらの結果は、本発明品が記憶力の改善作用を有するとともに、その改善作用は、これを継続的に摂取することにより、一層高まることを示すものである。   These results indicate that the product of the present invention has an improvement effect on memory ability, and the improvement effect is further enhanced by continuously taking it.

(脳機能改善用飲料剤等の効果確認試験III)
実施例1で得られた飲料剤等について、その脳機能改善効果を引き続きヒトで比較確認するため以下の試験を実施した。
(Effect confirmation test III for beverages for improving brain function III)
The following tests were carried out on the beverage obtained in Example 1 in order to continuously confirm the effect of improving brain function in humans.

身体的に健康な50乃至60歳のアルツハイマー型認知症の疑いのある者であって、認知症治療薬剤を投与していない10名(男女各5名)を被験者とし、試験例2に示す脳機能改善用飲料剤を毎日朝食後、100ml/日の割合で24週間に亘って飲用させた。なお、飲用の確認は、被験者以外の者が行った。飲用試験を開始してから25週間目に、各被験者に対し、認知症診断試験を行った。試験は、長谷川式簡易知能評価スケールに従った。長谷川式簡易知能評価スケールとは、年齢や場所を尋ねたり、簡単な言葉を記憶させることなどにより、記憶力・記銘力・見当識障害の症状を判断するために用いられる試験である。長谷川式簡易知能評価スケールにおいては、点数が高いほど、認知症の疑いが低いことを表す。本発明の脳機能改善用飲料の投与試験前後における被験者の点数の平均は、投与試験前においては19点(満点は30点で、20点以下は認知症の疑いあり)であったものが、投与試験後には23点となった。本試験結果から、投与試験前と比べ試験後には、被験者の記憶力・記銘力・見当識障害の症状は明らかに改善されていた。   The brains shown in Test Example 2 were 10 healthy subjects aged 50 to 60 who were suspected of having Alzheimer-type dementia and were not administered a dementia treatment drug (5 men and women). The function improving beverage was drunk for 24 weeks at a rate of 100 ml / day after breakfast every day. In addition, confirmation of drinking was performed by a person other than the subject. A dementia diagnostic test was performed on each subject 25 weeks after the start of the drinking test. The test followed the Hasegawa simplified intelligence evaluation scale. The Hasegawa-style simplified intelligence evaluation scale is a test used to determine the symptoms of memory, memorization, and disorientation by asking age and location, or by memorizing simple words. On the Hasegawa simplified intelligence evaluation scale, the higher the score, the lower the suspicion of dementia. The average score of subjects before and after the administration test of the beverage for improving brain function of the present invention was 19 points before the administration test (full score is 30 points, 20 points or less are suspected of dementia), The score was 23 after the administration test. From the results of this study, the subjects' memory, memory, and disorientation symptoms were clearly improved after the study compared to before the administration study.

また、本試験終了後、上記被験者全員につき、本発明品を飲用させないで、1カ月間通常の生活をさせた後、上記長谷川式簡易知能評価スケールを再度行ったところ、被験者の点数の平均は20点となった。   In addition, after the completion of this test, the above-mentioned Hasegawa simplified intelligence evaluation scale was performed again for all the subjects, after having had a normal life for one month without drinking the product of the present invention. 20 points.

これらの結果は、本発明品が記憶力・記銘力・見当識障害の症状の改善作用を有するとともに、これを継続的に摂取することにより効果的に奏せられることを示すものである。
この結果から、本発明品は、これを日常的に飲用することにより、加齢に伴う記憶・学習能力を効果的に改善するとともに、アルツハイマー病に代表される認知症などの脳神経疾患を効果的に改善し得るものである。
These results indicate that the product of the present invention has an effect of improving the symptom of memory ability, memorizing ability, and disorientation, and can be effectively produced by continuously taking it.
From this result, the product of the present invention effectively improves memory / learning ability associated with aging and can effectively treat cranial nerve diseases such as dementia typified by Alzheimer's disease. It can be improved.

(脳機能改善用飲料剤等の安全性確認試験)
本発明品の飲料剤等について、その安全性をマウスで確認するため以下の試験を実施した。
(Safety confirmation test for beverages for improving brain function)
The following tests were conducted on the beverages of the present invention in order to confirm their safety with mice.

参考例3の方法で得た中国パセリ水抽出物、糖転移ルチンとして、糖転移ルチン粉末(商品名『αGルチンPS』(固形分重量当りの全ルチン含量80乃至84%)、東洋精糖株式会社)、及び糖転移ヘスペリジンとして、糖転移ヘスペリジン粉末(商品名『林原ヘスペリジンS』(固形分重量当りの全ヘスペリジン含量70%以上)、株式会社林原商事)を常法にしたがってそれぞれ滅菌した。それら滅菌物をそれぞれ、体重20乃至25gのddyマウス(10匹/群)の腹腔内に注射投与するか、胃ゾンデにより経口投与した後、7日間に亙って経過を観察した。その結果、いずれの投与経路においても、『中国パセリ水抽出物』、『林原ヘスペリジンS』又は『αGルチンPS』を、試みた最大投与量である、マウス体重kg当り約10g投与の場合においてすら、死亡例は認められなかった。   Chinese parsley water extract obtained by the method of Reference Example 3 and sugar transfer rutin as sugar transfer rutin powder (trade name “αG rutin PS” (total rutin content 80 to 84% per solid weight), Toyo Seika Co., Ltd. ) And sugar-transferred hesperidin, sugar-transferred hesperidin powder (trade name “Hayashibara Hesperidin S” (total hesperidin content of 70% or more by weight of solid content), Hayashibara Corporation) was sterilized according to a conventional method. Each of these sterilized products was injected into the abdominal cavity of ddy mice (10 mice / group) weighing 20 to 25 g, or orally with a gastric sonde, and the course was observed over 7 days. As a result, “Chinese parsley water extract”, “Hayashibara Hesperidin S”, or “αG rutin PS” can be used in any of the administration routes, even in the case of about 10 g administration per kg body weight of the mouse. No deaths were observed.

本試験結果から、本発明の脳機能改善用飲料が有効成分とする中国パセリ水抽出物、糖転移ルチン、及び糖転移ヘスペリジンのいずれも、ヒトに投与可能な安全な物質である。   From the results of this test, Chinese parsley water extract, sugar-transferred rutin, and sugar-transferred hesperidin, which are active ingredients of the beverage for improving brain function of the present invention, are all safe substances that can be administered to humans.

実施例2乃至5の結果は、本発明品が、これを日常的に飲用することにより、加齢に伴う記憶・学習能力を効果的に改善するとともに、アルツハイマー病に代表される認知症などの脳神経疾患を効果的に改善し得るものであって、かつ、ヒトに投与可能な安全なものであることを裏付けるものである。   The results of Examples 2 to 5 show that the product of the present invention effectively improves the memory / learning ability associated with aging by drinking it on a daily basis, as well as dementia such as Alzheimer's disease. It supports that it can effectively improve cranial nerve diseases and is safe to administer to humans.

本発明を要約すれば、以下の通りである。   The present invention is summarized as follows.

本発明は、加齢に伴う記憶・学習能力を効果的に改善するとともに、アルツハイマー病に代表される認知症などの脳神経疾患を効果的に改善する、ヒトが安全かつ日常的に手軽に摂取することのできる脳機能改善用医薬品及び/又は飲食品の提供を目的とする。   The present invention effectively improves memory / learning ability associated with aging and effectively improves cranial nerve diseases such as dementia typified by Alzheimer's disease. The purpose is to provide a drug for improving brain function and / or food and drink.

そして、有効成分として、中国パセリ水抽出物を0.1乃至5質量%含有し、糖転移ルチン及び/又は糖転移ヘスペリジンを合計で0.1乃至10質量%含んでなる脳機能改善剤及び/又は飲食品により前記課題を解決する。   And a brain function improving agent comprising 0.1 to 5% by mass of Chinese parsley water extract as an active ingredient, and 0.1 to 10% by mass in total of sugar-transferred rutin and / or sugar-transferred hesperidin and / or Or the said subject is solved with food-drinks.

Claims (6)

有効成分として、中国パセリ水抽出物を0.1乃至5質量%含有し、糖転移ルチン及び/又は糖転移ヘスペリジンを合計で0.1乃至10質量%含んでなる脳機能改善剤。   A brain function improving agent comprising 0.1 to 5% by mass of Chinese parsley water extract as an active ingredient, and 0.1 to 10% by mass in total of transglycosyl rutin and / or transglycosyl hesperidin. 有効成分として、中国パセリ水抽出物を0.1乃至5質量%含有し、糖転移ルチン及び/又は糖転移ヘスペリジンを合計で0.1乃至10質量%含んでなり、かつ、pHが3乃至5である脳機能改善剤。   As an active ingredient, 0.1 to 5% by mass of Chinese parsley water extract, 0.1 to 10% by mass in total of sugar-transferred rutin and / or sugar-transferred hesperidin, and pH of 3 to 5 Is a brain function improving agent. コーヒー抽出物をさらに含むことを特徴とする、請求項1又は2に記載の脳機能改善剤。   The brain function improving agent according to claim 1 or 2, further comprising a coffee extract. 有効成分として、中国パセリ水抽出物を0.1乃至5質量%含有し、糖転移ルチン及び/又は糖転移ヘスペリジンを合計で0.1乃至10質量%含んでなる脳機能改善用飲食品。   A food and drink for improving brain function comprising 0.1 to 5% by mass of Chinese parsley water extract as an active ingredient, and 0.1 to 10% by mass in total of sugar-transferred rutin and / or sugar-transferred hesperidin. 有効成分として、中国パセリ水抽出物を0.1乃至5質量%含有し、糖転移ルチン及び/又は糖転移ヘスペリジンを合計で0.1乃至10質量%含んでなり、かつ、pHが3乃至5である脳機能改善用飲食品。   As an active ingredient, 0.1 to 5% by mass of Chinese parsley water extract, 0.1 to 10% by mass in total of sugar-transferred rutin and / or sugar-transferred hesperidin, and pH of 3 to 5 Food and drink for improving brain function. コーヒー抽出物をさらに含むことを特徴とする、請求項4又は5に記載の脳機能改善用飲食品。   The food or drink for improving brain function according to claim 4 or 5, further comprising a coffee extract.
JP2011152225A 2011-07-08 2011-07-08 Brain function improving agent and food and drink for improving brain function Expired - Fee Related JP5779796B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011152225A JP5779796B2 (en) 2011-07-08 2011-07-08 Brain function improving agent and food and drink for improving brain function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011152225A JP5779796B2 (en) 2011-07-08 2011-07-08 Brain function improving agent and food and drink for improving brain function

Publications (2)

Publication Number Publication Date
JP2013018731A true JP2013018731A (en) 2013-01-31
JP5779796B2 JP5779796B2 (en) 2015-09-16

Family

ID=47690538

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011152225A Expired - Fee Related JP5779796B2 (en) 2011-07-08 2011-07-08 Brain function improving agent and food and drink for improving brain function

Country Status (1)

Country Link
JP (1) JP5779796B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20163931A1 (en) * 2016-05-30 2017-11-30 Biofordrug S R L MIXTURES OF COFFEE FOR NEUROPROTECTION

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002275079A (en) * 2001-03-15 2002-09-25 Fancl Corp Composition for enhancing gltathione
US20060099239A1 (en) * 2002-04-15 2006-05-11 Coleman Henry D Dietary supplement for promoting removal of heavy metals from the body

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002275079A (en) * 2001-03-15 2002-09-25 Fancl Corp Composition for enhancing gltathione
US20060099239A1 (en) * 2002-04-15 2006-05-11 Coleman Henry D Dietary supplement for promoting removal of heavy metals from the body

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6015023087; Journal of Ethnopharmacology Vol.113, No.3, 2007, p.363-381 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20163931A1 (en) * 2016-05-30 2017-11-30 Biofordrug S R L MIXTURES OF COFFEE FOR NEUROPROTECTION

Also Published As

Publication number Publication date
JP5779796B2 (en) 2015-09-16

Similar Documents

Publication Publication Date Title
JP5793739B2 (en) Pharmaceutical composition for treatment or prevention of reflux esophagitis comprising gold and silver flower extract
KR102303570B1 (en) Agent or method for treatment and/or prevention of accelerated energy expenditure and/or diminished energy expenditure functionality
JPWO2005074960A1 (en) Functional beverages and compositions
JPWO2007023931A1 (en) Composition for suppressing increase in blood alcohol concentration
JPWO2012121140A1 (en) Growth hormone secretagogue
WO2014017243A1 (en) Sleep quality improving agent
WO2007119588A1 (en) Brain function-improving agent, and functional food containing the improving agent
JP2005336078A (en) Masking agent
JP2011136916A (en) Acidic food and beverage containing 2,5-piperazinedione, 3,6-bis(phenylmethyl)-, (3s, 6s)-
KR20070095338A (en) Hepatic function remedial agent
WO2005074961A1 (en) Body fat-controlling agent
JP4494033B2 (en) Serum cholesterol lowering agent, food and drink, and method for producing the same
JP5779796B2 (en) Brain function improving agent and food and drink for improving brain function
JP7229513B2 (en) Brain function improving agent and food and drink for improving brain function
KR102645410B1 (en) Lithium salts of N-substituted glycine compounds and uses thereof
WO2020154712A1 (en) Compositions and methods for improving quality of life in patients with autism spectrum disorder
CN107614000A (en) Brain function protective agent
JP4993515B2 (en) Oleic acid-containing composition and use thereof
JP2013249260A (en) Senescence retardant
JP6544503B2 (en) Cosmetic composition and functional food containing collagenase inhibitor and collagenase inhibitor
JP2021078397A (en) Lipid decrease promoter
JP2009107945A (en) Inhibitor of optic nerve disorder and food and drink containing the same
JP4954295B2 (en) Pharmaceutical composition for protecting liver function comprising arazyme as an active ingredient
JP4873605B2 (en) A composition having an angiogenesis-inhibiting action comprising a cereal-derived ingredient as an active ingredient
KR101658403B1 (en) Natural sugar syrup and manufacturing process thereof

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140624

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140704

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140624

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150616

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150622

R150 Certificate of patent or registration of utility model

Ref document number: 5779796

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees